“We are thrilled to announce the launch of Earwax MD and Ear Pain MD in the full chain of Rite Aid stores,” said Elyse Dickerson, CEO of Eosera. “Customers will be able to find the product in the ear care aisle of all Rite Aid stores starting in May. Our goal is to make our products easily accessible to the millions of shoppers searching for innovative solutions for their ear care needs.”
Earwax (cerumen) accumulation is a healthy, useful process that normally resolves naturally. However, cerumen can become impacted when earwax accumulates and hardens within the ear canal, potentially causing discomfort, tinnitus, and hearing loss. Too often, because earwax is perceived as “dirty,” sufferers may avoid seeking help until symptoms become very pronounced.
While the total earwax removal category is up 7.8% for the year (AC Nielsen), Earwax MD is reportedly “up 166%” in the same period, according to the company. Retailers that have Earwax MD on the shelf have reportedly seen their category grow as much as 30%, outpacing the market, the company states.
Making a Difference
From baby drops to ear candles, traditional cerumen remedies are readily available but unfortunately, not proven effective, according to Eosera’s press statement. With its “proprietary mix of glycolic acid and various buffering agents,” though, Earwax MD is said to “dissolve and clean away” hardened wax build unlike other remedies on the market.
“My client had a very old and hard impaction and was not thrilled at the prospect of removing it,” said Janie York, owner of Omaha, Neb-based Hear Now mobile hearing solutions. “He agreed to try Earwax MD, however. After 20 minutes, I could see how much softer it was. The entire impaction came out with a combination of lighted curette and irrigation with no discomfort to my client. He could hear so much better and was so grateful! This is the only product I use for cerumen management, and I highly recommend it for any hearing care practice.”
A clinical study that details Eosera’s results can be found on NIH.gov.
Founded in 2015, Fort Worth, TX-based Eosera develops products that address underserved medical needs. Additional information can be found at www.eosera.com.
Elyse Stoltz Dickerson is CEO and Co-founder of Eosera, Inc, a majority woman-owned biotech company committed to developing innovative products that address underserved healthcare needs. Elyse was also awarded the Dallas Business Journal 2018 Women in Business Award. Most recently, she was named Fort Worthian to Watch in 2019 by Fort Worth Magazine.
Elyse has seventeen years of experience leading teams in the healthcare and pharmaceutical industries. She has managed portfolios with annual revenues of US$1.7 Billion, and driven product innovation and the commercialization of numerous technologies across the globe.